Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Grant/Award of 45,000 ARTV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 45,000 | n/a |
| Jun 26, 2026 | Contineum Therapeutics, Inc. (CTNM) | Grant/Award | 19,000 | n/a |
| May 19, 2026 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 77,500 | n/a |
| Jun 26, 2025 | Contineum Therapeutics, Inc. (CTNM) | Grant/Award | 14,750 | n/a |
| Jun 26, 2025 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 13,750 | n/a |
| Mar 17, 2025 | Contineum Therapeutics, Inc. (CTNM) | Grant/Award | 29,500 | n/a |